Successful management of pregnancy with dual mechanical heart valves: a case report

Authors

  • Pallavi Mishra Department of Obstetrics and Gynecology, Mediheal Hospital and Fertility Center, Eldoret, Uasin Gishu County, Kenya
  • Neha Singh Department of Obstetrics and Gynecology, Mediheal Hospital and Fertility Center, Eldoret, Uasin Gishu County, Kenya

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20222485

Keywords:

Heart diseases in pregnancy, Rheumatic heart diseases, Mechanical heart valves in pregnancy, Anticoagulants in pregnancy

Abstract

Incidence of cardiovascular diseases in pregnancy is increasing due to advanced maternal age at first conception and frequent association of comorbid chronic medical conditions. Rheumatic heart diseases comprise 56-89% of all CVDs in pregnancy in non-western countries. Management of pregnant women with mechanical valves is very challenging due to high risk of cardiac and non-cardiac complications either due to heart disease itself or changes in hemodynamics during pregnancy or due to anticoagulant therapy. We presented here a case of a 35-year-old pregnant woman with rheumatic heart disease with dual mechanical (aortic and mitral) valve replacement who was managed successfully by our team of expert clinicians with intensive antepartum surveillance with good obstetric outcome. It is very important for managing clinicians to have necessary information about high-risk cardiovascular diseases during pregnancy along with their management and treatment related feto-maternal complications in order to have optimal feto-maternal outcome.

Author Biographies

Pallavi Mishra, Department of Obstetrics and Gynecology, Mediheal Hospital and Fertility Center, Eldoret, Uasin Gishu County, Kenya

Consultant Obstetrician & Gynecologist and Maternal-Fetal Medicine expert

Neha Singh, Department of Obstetrics and Gynecology, Mediheal Hospital and Fertility Center, Eldoret, Uasin Gishu County, Kenya

Consultant Obstetrician & Gynecologist

References

Elkayam U, Goland S, Pieper PG, Silverside CK. High-Risk Cardiac Disease in Pregnancy: Part I. J Am Coll Cardiol. 2016;68(4):396-410.

Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165-241.

Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515-21.

Domènech A, Galian L, Goya M, Casellas M, Merced C, Ferreira-Gonzalez I, et al. Cardiac complications during pregnancy are better predicted with the modified WHO risk score. Int J Cardiol. 2015;195:149-54.

Ginsberg JS, Chan WS, Bates SM, Kaatz S. Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med. 2003;163(6):694-8.

D'Souza R, Ostro J, Shah PS, Silversides CK, Malinowski A, Murphy KE, et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Eur Heart J. 2017;38(19):1509-16.

Ashour ZA, Shawky HA, Hassan Hussein M. Outcome of pregnancy in women with mechanical valves. Tex Heart Inst J. 2000;27(3):240-5.

Downloads

Published

2022-09-27

Issue

Section

Case Reports